Search Results

Filter
  • 1-10 of  4,388 results for ""Fluconazole""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Mangiferin potentiates the activity of antifungal agents against fluconazole-resistant Candida spp.

  • Authors : Ferreira TL; Department of Clinical & Toxicological Analysis, Faculty of Pharmacy, Laboratory of Bioprospection in Antimicrobial Molecules (LABIMAN), Federal University of Ceará, Fortaleza 60.430-370, Ceará, Brazil.; Drug Research and Development Center, Federal University of Ceará, Fortaleza 60.430-275, Ceará, Brazil.

Subjects: Antifungal Agents*/Antifungal Agents*/Antifungal Agents*/pharmacology ; Xanthones*/Xanthones*/Xanthones*/pharmacology ; Fluconazole*/Fluconazole*/Fluconazole*/pharmacology

  • Source: Future microbiology [Future Microbiol] 2024 Sep; Vol. 19 (13), pp. 1157-1170. Date of Electronic Publication: 2024 Jul 16.Publisher: Future Medicine Country of Publication: England NLM ID: 101278120 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Response of Fusarium oxysporum soil isolate to amphotericin B and fluconazole at the proteomic level.

  • Authors : Amatto IVDS; Department of Pharmaceutical Sciences, School of Pharmaceutical Sciences, University of São Paulo, Ribeirão Preto, Brazil.; Simões FAO

Subjects: Fusarium*/Fusarium*/Fusarium*/drug effects ; Fusarium*/Fusarium*/Fusarium*/metabolism ; Fusarium*/Fusarium*/Fusarium*/genetics Fusarium oxysporum

  • Source: Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] [Braz J Microbiol] 2024 Sep; Vol. 55 (3), pp. 2557-2568. Date of Electronic Publication: Publisher: Springer International Publishing Country of Publication: Brazil NLM ID: 101095924 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Antifungal susceptibility profile of Candida species and uncommon yeasts from drug abusers with oral candidiasis.

  • Authors : Ghojoghi A; Department of Medical Mycology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.; Cellular and Molecular Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Subjects: Antifungal Agents*/Antifungal Agents*/Antifungal Agents*/pharmacology ; Antifungal Agents*/Antifungal Agents*/Antifungal Agents*/therapeutic use ; Microbial Sensitivity Tests*

  • Source: BMC oral health [BMC Oral Health] 2024 Dec 26; Vol. 24 (1), pp. 1555. Date of Electronic Publication: 2024 Dec 26.Publisher: BioMed Central Country of Publication: England NLM ID: 101088684 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6831

Record details

×
Academic Journal

From Histoplasmosis to Cryptococcosis: A diagnostic journey of pediatric scalp abscess.

  • Authors : Paul D; Department of Microbiology, All India Institute of Medical Sciences, Bhubaneswar, 751019, India. Electronic address: .; Satpathy A

Subjects: Cryptococcosis*/Cryptococcosis*/Cryptococcosis*/diagnosis ; Cryptococcosis*/Cryptococcosis*/Cryptococcosis*/drug therapy ; Cryptococcosis*/Cryptococcosis*/Cryptococcosis*/microbiology

  • Source: Indian journal of medical microbiology [Indian J Med Microbiol] 2024 Nov-Dec; Vol. 52, pp. 100753. Date of Electronic Publication: 2024 Nov 20.Publisher: Elsevier Country of Publication: United States NLM ID: 8700903 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Evaluation of the Vitek 2 system for antifungal susceptibility testing of Candida auris using a representative international panel of clinical isolates: overestimation of amphotericin B resistance and underestimation of fluconazole resistance.

  • Authors : Siopi M; Clinical Microbiology Laboratory, 'Attikon' University General Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.; Molecular Microbiology and Immunology Laboratory, Department of Biomedical Sciences, University of West Attica, Athens, Greece.

Subjects: Fluconazole*/Fluconazole*/Fluconazole*/pharmacology ; Amphotericin B*/Amphotericin B*/Amphotericin B*/pharmacology; Humans

  • Source: Journal of clinical microbiology [J Clin Microbiol] 2024 Apr 10; Vol. 62 (4), pp. e0152823. Date of Electronic Publication: 2024 Mar 19.Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 7505564 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Paeonol enhances treatment of fluconazole and amphotericin B against oropharyngeal candidiasis through HIF-1α related IL-17 signaling.

  • Authors : Pan M; Laboratory of Infection and Immunity, College of Integrated Chinese and Western Medicine (College of Life Science), Anhui University of Chinese Medicine, Zhijing Building, 350 Longzihu Road, Xinzhan District, Hefei 230012, Anhui, P. R. China.; Wang Q

Subjects: Acetophenones*/Acetophenones*/Acetophenones*/pharmacology ; Acetophenones*/Acetophenones*/Acetophenones*/therapeutic use ; Amphotericin B*/Amphotericin B*/Amphotericin B*/pharmacology

  • Source: Medical mycology [Med Mycol] 2022 Mar 04; Vol. 60 (3).Publisher: Oxford University Press Country of Publication: England NLM ID: 9815835 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Adaptation to Fluconazole via Aneuploidy Enables Cross-Adaptation to Amphotericin B and Flucytosine in Cryptococcus neoformans.

  • Authors : Yang F; Department of Pharmacy, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.; Shmunis School of Biomedical and Cancer Research, The George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel.

Subjects: Aneuploidy*; Adaptation, Physiological/Adaptation, Physiological/Adaptation, Physiological/*drug effects ; Amphotericin B/Amphotericin B/Amphotericin B/*pharmacology

  • Source: Microbiology spectrum [Microbiol Spectr] 2021 Oct 31; Vol. 9 (2), pp. e0072321. Date of Electronic Publication: 2021 Sep 29.Publisher: ASM Press Country of Publication: United States NLM ID: 101634614 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Paeonol assists fluconazole and amphotericin B to inhibit virulence factors and pathogenicity of Candida albicans .

  • Authors : Pan M; Laboratory of Infection and Immunity, College of Integrated Chinese and Western Medicine (College of Life Science), Anhui University of Chinese Medicine, Hefei, P. R. China.; Wang Q

Subjects: Amphotericin B*/Amphotericin B*/Amphotericin B*/pharmacology ; Fluconazole*/Fluconazole*/Fluconazole*/pharmacology; Acetophenones

  • Source: Biofouling [Biofouling] 2021 Sep; Vol. 37 (8), pp. 922-937. Date of Electronic Publication: 2021 Oct 06.Publisher: Taylor & Francis Country of Publication: England NLM ID: 9200331 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

In Vitro and In Vivo Antifungal Activity of AmBisome Compared to Conventional Amphotericin B and Fluconazole against Candida auris.

  • Authors : Herrada J; Center for Medical Mycology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.; Case Western Reserve University, Cleveland, Ohio, USA.

Subjects: Amphotericin B*/Amphotericin B*/Amphotericin B*/pharmacology ; Fluconazole*/Fluconazole*/Fluconazole*/pharmacology; Antifungal Agents/Antifungal Agents/Antifungal Agents/pharmacology Candida auris infection

  • Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2021 May 18; Vol. 65 (6). Date of Electronic Publication: 2021 May 18 (Print Publication: 2021).Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Electronic-Print Cited Medium:

Record details

×
Academic Journal

Categorizing Susceptibility of Clinical Isolates of Candida auris to Amphotericin B, Caspofungin, and Fluconazole by Use of the CLSI M44-A2 Disk Diffusion Method.

  • Authors : Nunnally NS; Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA .; Damm T

Subjects: Amphotericin B*/Amphotericin B*/Amphotericin B*/pharmacology ; Fluconazole*/Fluconazole*/Fluconazole*/pharmacology; Antifungal Agents/Antifungal Agents/Antifungal Agents/pharmacology

  • Source: Journal of clinical microbiology [J Clin Microbiol] 2021 Mar 19; Vol. 59 (4). Date of Electronic Publication: 2021 Mar 19 (Print Publication: 2021).Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 7505564 Publication Model: Electronic-Print Cited Medium:

Record details

×
  • 1-10 of  4,388 results for ""Fluconazole""